BioSpace News Archive

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today provided an update on in its investment portfolio including Choklat Inc. (“Choklat”) and Pineapple Express Delivery Inc. (“Pineapple Express”).

Henry Schein, Inc. (Nasdaq: HSIC) today announced that it has awarded its fourth annual Henry Schein Cares Medal in the Medical category to Shawnee, Oklahoma-based Youth and Family Resource Center.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that they achieved 27% revenue growth and 79% EBITDA growth in the first half of 2019 over the same period in 2018.

Immuno-oncology is considered a promising new treatment for detecting and destroying tumors, giving cancer patients hope of a longer life

Applied StemCell is excited to announce the recent publication of A System for Site-specific Integration of Transgenes in Mammalian Cells in PLOS ONE.

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a specific and permanent reimbursement J-code, through the Healthcare Common Procedure Coding System (HCPCS) for DEXTENZA

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to extend the current marketing authorization of SOLIRIS® (eculizumab) to include the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive with a relapsing course of the disease

Hologic’s (Nasdaq: HOLX) Cynosure division announced today the launch of two new products that expand the Company’s growing portfolio of innovative aesthetic treatments — the TempSure® Firm handpiece and a petite mask for SculpSure® submental treatments

Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending INBRIJA’s approval by the European Commission (EC).

Teaches Patient Management and Triage in a simulated Mass Casualty Incident caused by an explosion. [26-July-2019] RANCHO CUCAMONGA, Calif. , July 26, 2019 /PRNewswire/ -- Disaster Management Systems, Inc., the nation’s leading supplier of disaster preparedness solutions, today announced the availability of a new tabletop training kit designed to acquaint first respon